Final analysis of a randomized comparison of letrozole (Let) vs observation (Obs) as late reintroduction of adjuvant endocrine therapy (AET) for postmenopausal women with hormone receptor positive (HR+) breast cancer (BC) after completion of prior AET: ANZBCTG 0501 (LATER)

Abstract only

Saved in:
Bibliographic Details
Published in:Journal of clinical oncology Vol. 33; no. 15_suppl; p. 514
Main Authors: Zdenkowski, Nicholas, Green, Michael, Boyle, Frances M., Kannourakis, George, Gill, Peter Grantley, Bayliss, Evan, Saunders, Christobel, Della-Fiorentina, Stephen, Kling, Neill, Campbell, Ian, Gebski, Val, Veillard, Anne-Sophie, Davies, Lucy Claire, Thornton, Rochelle, Fong, Akiko, Reaby, Linda Louise, Forbes, John F.
Format: Journal Article
Language:English
Published: 20-05-2015
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2015.33.15_suppl.514